Biotinylated GHK in Collagen Matrix Accelerates Diabetic Wound Healing in Rats
Background
Diabetic wound healing is severely impaired by chronically elevated blood glucose, which reduces leukocyte function and causes cell malnutrition, leading to high rates of wound infection and failed tissue repair. Standard wound care for diabetic patients remains inadequate at correcting the underlying oxidative stress and extracellular matrix deficits. GHK (glycyl-L-histidyl-L-lysine) is a naturally occurring copper-binding tripeptide with known roles in stimulating collagen synthesis and fibroblast activation. Biotinylation of GHK was explored as a strategy to enhance peptide incorporation and retention within a collagen biomaterial scaffold, enabling controlled local delivery at the wound site.
Study Design
Biotinylated GHK (BioGHK) incorporated collagen (Peptide Incorporated Collagen — PIC) was applied topically to excisional wounds in streptozotocin-induced diabetic rats. Three groups were compared: untreated control, Collagen Film (CF), and PIC. Endpoints included rate of wound contraction, and biochemical quantification of collagen, uronic acid, total protein, and DNA in granulation tissue. Nitric oxide, glutathione (GSH), ascorbic acid, SOD, and CAT activity were measured in skin. In vitro fibroblast proliferation assays and histological assessment via haematoxylin-eosin and Masson's trichrome staining were also performed.
Results
PIC-treated diabetic rats showed a hastened healing process with an increased rate of wound contraction compared to both untreated controls and CF-treated animals. Glutathione (GSH) and ascorbic acid levels in the skin were higher in the PIC group relative to untreated control and CF groups, indicating improved antioxidant capacity. Superoxide dismutase (SOD) and catalase (CAT) activity were altered across all groups, with changes most pronounced in the PIC arm. Nitric oxide concentration was monitored and found to differ between groups during the study period.
PIC promoted in vitro fibroblast growth and histological analysis confirmed increased collagen synthesis, epithelialization, and activation of both fibroblasts and mast cells exclusively in the PIC group.
Granulation tissue biochemistry (collagen, uronic acid, protein, DNA content) collectively supported enhanced tissue remodeling in the PIC cohort.
Key Findings
- PIC increased wound contraction rate vs. untreated control and collagen-film groups in diabetic rats
- GSH and ascorbic acid levels in skin were higher in the PIC group than in control and CF groups
- SOD and CAT activity was altered across all three treatment groups
- In vitro fibroblast culture studies showed PIC promotes fibroblast proliferation
- Histology confirmed epithelialization, increased collagen synthesis, and fibroblast/mast cell activation in PIC group
Why It Matters
Topical BioGHK-collagen matrices represent a feasible, combinatorial biomaterial strategy for a patient population — diabetics — where conventional wound dressings regularly fail. The dual mechanism of structural collagen scaffold plus bioactive peptide delivery addresses both the physical and biochemical deficits of impaired healing simultaneously. For clinicians and formulators, the biotinylation approach is noteworthy: biotinylation may improve peptide anchoring and sustained release within collagen films, a technique potentially transferable to other peptide-wound care applications. Translation to human use requires further pharmacokinetic data, dose-ranging studies, and controlled clinical trials, but the streptozotocin-rat model provides a well-validated first step. Practitioners interested in GHK-Cu topical protocols should note that this study used a biotinylated, matrix-embedded format — free GHK or GHK-Cu in solution was not the comparator — meaning direct extrapolation to standalone GHK-Cu creams requires caution.
